Autocrine motility factors in cancer diagnosis and management

Details Autocrine motility factors in cancer diagnosis and management Autocrine motility factors in cancer diagnosis and management

C - Chemistry, Metallurgy

07

K

167/37

C07K 14/47 (2006.01) C07K 16/18 (2006.01) C07K 16/30 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1310902

ABSTRACT OF THE DISCLOSURE The present invention described an isolated and substantially pure mammalian cell polypeptide which stimulates random locomotion of producer cell and which has a molecular weight greater than 30,000. The unique polypeptide of the present invention is inhibited by pertussis toxin. A kit and method for detecting metastastis in human are also described.

568290

Affiliated with

Also associated with

Rating

Autocrine motility factors in cancer diagnosis and management does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Autocrine motility factors in cancer diagnosis and management, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autocrine motility factors in cancer diagnosis and management will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1281905